Platform tech for ultra-rapid, instrument-free, point-of-care assays that provide lab-grade precision under one minute anywhere
Chemeleon has raised $1.7M in total funding. The most recent round was Grant. The last funding was announced in January 2023.
Chemeleon's investors include National Science Foundation, National Institutes of Health, Good Libations LLC.
Chemeleon is headquartered in Brooklyn, United States.
Platform tech for ultra-rapid, instrument-free, point-of-care assays that provide lab-grade precision under one minute anywhere
Chemeleon is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Chemeleon — Funding & Investors." VCBacked, January 2, 2023, https://www.vcbacked.co/company/chemeleon. Accessed July 21, 2026.
VCBacked. (2023). Chemeleon — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/chemeleon
{{cite web |title=Chemeleon — Funding & Investors |url=https://www.vcbacked.co/company/chemeleon |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated